Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Diffuse glioneuronal tumour with oligodendroglioma‐like features and nuclear clusters (DGONC) – a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14.

Autor: Deng, M. Y.^1,2 (AUTHOR), Sill, M.^1,3 (AUTHOR), Sturm, D.^1,2,4 (AUTHOR), Stichel, D.^5,6 (AUTHOR), Witt, H.^1,3,4 (AUTHOR), Ecker, J.^1,4,7 (AUTHOR), Wittmann, A.^1,2 (AUTHOR), Schittenhelm, J.⁸ (AUTHOR), Ebinger, M.⁹ (AUTHOR), Schuhmann, M. U.¹⁰ (AUTHOR), Figarella‐Branger, D.¹¹ (AUTHOR), Aronica, E.¹² (AUTHOR), Staszewski, O.¹³ (AUTHOR), Preusser, M.¹⁴ (AUTHOR), Haberler, C.¹⁵ (AUTHOR), Lauten, M.¹⁶ (AUTHOR), Schüller, U.¹⁷ (AUTHOR), Hartmann, C.¹⁸ (AUTHOR), Snuderl, M.¹⁹ (AUTHOR), Dunham, C.²⁰ (AUTHOR)

Publikováno v: Neuropathology & Applied Neurobiology. Aug2020, Vol. 46 Issue 5, p422-430. 9p.

Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated

Autor: Maas, SLN, Stichel, D, Hielscher, T, Sievers, P, Berghoff, AS, Schrimpf, D, Sill, M, Euskirchen, P, Blume, C, Patel, A, Dogan, H, Reuss, D, Dohmen, H, Stein, M, Reinhardt, A, Suwala, AK, Wefers, AK, Baumgarten, P, Ricklefs, F, Rushing, EJ, Bewerunge-Hudler, M, Ketter, R, Schittenhelm, J, Jaunmuktane, Z, Leu, S, Greenway, FEA, Bridges, LR, Jones, T, Grady, C, Serrano, J, Golfinos, J, Sen, C, Mawrin, C, Jungk, C, Hänggi, D, Westphal, M, Lamszus, K, Etminan, N, Jungwirth, G, Herold-Mende, C, Unterberg, A, Harter, PN, Wirsching, H-G, Neidert, MC, Ratliff, M, Platten, M, Snuderl, M, Aldape, KD, Brandner, S, Hench, J, Frank, S, Pfister, SM, Jones, DTW, Reifenberger, G, Acker, T, Wick, W, Weller, M, Preusser, M, von Deimling, A, Sahm, F, German Consortium on Aggressive Meningiomas (KAM)

PURPOSE: Meningiomas are the most frequent primary intracranial tumors. Patient outcome varies widely from benign to highly aggressive, ultimately fatal courses. Reliable identification of risk of progression for individual patients is of pivotal imp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::c2bcbd3260570cd7a78a0990e862302b
https://openaccess.sgul.ac.uk/id/eprint/114144/1/jco.21.00784.pdf